CRISPR-Cas9 technology

GPTKB entity

Statements (53)
Predicate Object
gptkbp:instanceOf gptkb:biotechnology
genome editing technology
molecular biology tool
gptkbp:appliesTo biomedical engineering
synthetic biology
pharmaceutical development
functional genomics
crop improvement
animal model creation
human disease research
gptkbp:basedOn gptkb:CRISPR
gptkb:Cas9_protein
gptkbp:component gptkb:Cas9_endonuclease
gptkb:guide_RNA
gptkbp:controversy patent disputes
ethical concerns
germline editing
off-target effects
gptkbp:developedBy gptkb:Emmanuelle_Charpentier
gptkb:Jennifer_Doudna
gptkbp:enables gene knock-in
gene knock-out
multiplexed gene editing
targeted genome modification
gptkbp:firstPublished 2012
https://www.w3.org/2000/01/rdf-schema#label CRISPR-Cas9 technology
gptkbp:mechanismOfAction induces double-strand breaks in DNA
relies on RNA-guided DNA targeting
gptkbp:NobelPrizeYear gptkb:Emmanuelle_Charpentier
gptkb:Jennifer_Doudna
2020
gptkbp:notablePatentDispute University of California, Berkeley vs. Broad Institute
gptkbp:regulates regulated by international agreements
regulated by national laws
subject to bioethics guidelines
gptkbp:relatedTo gptkb:gene_drive
gptkb:CRISPR
gptkb:Cas9
genome editing
base editing
prime editing
gptkbp:usedFor gptkb:agricultural_machinery
biomedical research
gene editing
genome engineering
gene therapy
disease modeling
genetic research
gene activation
gene knockout
gene repression
gptkbp:bfsParent gptkb:Caribou_Biosciences
gptkbp:bfsLayer 5